TCL Archive Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events June 28, 2013
TCL Archive Treatment Progress Since 1972 Provides Powerful Support For Continuing National Cancer Program March 23, 1979